Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
New Hope for HIV Eradication
New Synthetic Proteins Block HIV
Additional Funding Awarded for Adherence Breathalyzer
A New Avenue Opens for Treating KS, CMV and Other Herpes Diseases
New Life for Treatment Interruptions?
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

May 19, 2008

Viracept OK Again for Children, Pregnant Women

Pfizer has met new manufacturing standards set by the Food and Drug Administration (FDA) for Viracept (nelfinavir), and the drug is now considered safe again for use in children and pregnant women in the United States, according to a letter sent to health care providers by Pfizer earlier this month. Pfizer is still in negotiations with Canadian regulators for distribution there, and Roche, the distributor of Viracept in Europe, hasn’t yet brought the product back onto the market there despite having its license reinstated.

In September 2007, Pfizer alerted patients and providers that higher-than-acceptable levels of ethyl methanesulfonate (EMS), an impurity that occurs during the manufacturing of Viracept, had been found in U.S. batches of the drug. Because EMS may be cancer-causing, Pfizer and the FDA warned children and pregnant women against using the drug until safe limits for the impurity could be determined.  In Europe, Viracept was recalled from all markets and Roche’s license to sell the drug was suspended.

Pfizer states that as of March 31, 2008, all supplies of the drug currently available for sale in the U.S. meet the new FDA manufacturing standards, and that recommendations warning against the use of the drug in children and pregnant women are no longer necessary.

The license to market Viracept in Europe has been reinstated, but Roche has not yet returned to selling the drug. Pfizer is waiting on the Canadian government to set an EMS safety level so that use among children and pregnant women can once again be permitted.

Search: Pfizer, Viracept, nelfinavir, FDA, ethyl methanesulfonate, EMS


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 2 (of 2 total)    

Lady Bug, , 2009-02-09 03:35:56
My dc4 count is below 100. I'm 3 months pregnant and healthy as anyone out there. My Dr. recommends that I go on ARV's for the rest of my pregnancy and the rest of my life. I'm 28 and don't want to be on ARV's for the rest of my life. I there any other way that I can have a healty baby without taking ARV's for the rest of my life? maybe something temporaty? Please help!

Shashank Tiwari, Gwalior, 2008-12-05 02:59:43
Thank you

comments 1 - 2 (of 2 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

CROI 2009
Montréal, Canada
February 8-11, 2009


48th Annual ICAAC/IDSA 46th Annual Meeting
Washington, DC
October 25-28, 2008


XVII International AIDS Conference
Mexico City, Mexico
August 3-8, 2008


more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy